Visible Patient Suite— 510(k) K212896

Substantially Equivalent

Visible Patient, Sas

FDA 510(k) clearance K212896 for Visible Patient Suite, Substantially Equivalent on 2021-11-05. Applicant: Visible Patient, Sas.

Clearance details

Applicant: Visible Patient, Sas
Product code: Code LLZ
Advisory panel: Radiology
Date received: 2021-09-10
Decision date: 2021-11-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Strasbourg, FR

Download summary PDF View on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.